24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Clinical Trials
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:38
Who will cover the damages of the largest computer failure in history?
16:00
Scopio Labs secures $42 million Series D for AI-based blood cell analysis
14:47
"Growing high-tech is essential for the economy of the North"
14:31
Full list of Israeli high-tech funding rounds in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
The Gili Ra’anan model: Questions emerging from Cyberstarts' remarkable success
2
JPMorgan CEO Jamie Dimon makes whirlwind visit to Israel
3
From IPO dreams to CrowdStrike’s crisis: Inside the collapse of the Wiz-Google mega deal
4
Israel’s Quantum Transistors receives €17.5M from the European Innovation Council for its quantum computing solution
5
Amdocs set to cut 1,500-3,000 jobs in new round of layoffs
More news
Clinical Trials
4 stories about Clinical Trials
ReWalk Launches Clinical Trials for Robotic Physical Rehab Suit
04.04.18
|
Asaf Shalev
After the conclusion of the 40-person trial, the company will seek clearance from U.S. and European regulators
Company that Develops Injectable Bone Grafts Expands Clinical Trial
12.03.18
|
Dror Reich
Unlike conventional methods, Bonus Biogroup turns fat tissue collected from patients into bone grafts that can be transplanted with a minimally invasive procedure
Bonus Biogroup Says First Lab-Grown Leg Bone Transplanted in Patient
21.12.17
|
Lilach Baumer
The Israel-based company's injectable bone grafts are made from fat cells taken from the patients to negate the risk of tissue rejection
Automated Medical Diagnosis Startup Raises $30 Million
19.09.17
|
Omer Kabir
Israel-based MeMed develops an automated blood testing device that can distinguish between bacterial and viral infections. The company previously raised funds from the U.S. Department of Defense
Please ensure Javascript is enabled for purposes of
website accessibility